Arix Bioscience PLC (LON:ARIX)

Arix Bioscience PLC (LON:ARIX)

Share Price
131.00 p
0 (0.00 %)
Market Cap
£177.57 m
Proactive Investors - Run By Investors For Investors

Arix Bioscience PLC RNS Release

Arix Bioscience Plc - Issue of Ordinary Shares and Total Voting Rights

Arix Bioscience Plc - Issue of Ordinary Shares and Total Voting Rights

PR Newswire

Arix Bioscience plc

Issue of Ordinary Shares and Total Voting Rights

Arix Bioscience plc (the "Company") announces that it has allotted 530,000 new Ordinary Shares to the Arix Bioscience plc Employee Benefit Trust in order to satisfy awards made under the Arix Bioscience plc Executive Incentive Plan.

Application has been made for 530,000 new Ordinary Shares to be admitted to the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange. The new Ordinary Shares will rank pari passu with the existing ordinary shares and it is expected that admission of these new Ordinary Shares will take place at 8.00 a.m. on 2 May 2019.

Following the issue of 530,000 shares the Company will have a total of 135,467,601 ordinary shares of £0.00001 each in issue and a total number of voting rights in the Company of 135,467,601. The above figure of 135,467,601 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

Robert Lyne                        Company Secretary                         +44 (0)207 290 1050

 - Ends -

Arix Bioscience PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use